Mariner, LLC Ligand Pharmaceuticals Inc Transaction History
Mariner, LLC
- $58.4 Billion
- Q4 2024
A detailed history of Mariner, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Mariner, LLC holds 2,574 shares of LGND stock, worth $293,255. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,574Holding current value
$293,255% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
275Shares Held
18.5MCall Options Held
28.8KPut Options Held
7K-
Black Rock Inc. New York, NY2.87MShares$327 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$238 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.02MShares$116 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3884KShares$101 Million0.11% of portfolio
-
State Street Corp Boston, MA744KShares$84.7 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.92B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...